Castro, B. A. D., Rendo, C. R., Calvo, L., Lopez, E. P., Novoa, S. A. (2025). Should toxicity be taken into account in determining chemotherapy backbone in HER2-positive (HER2+) early breast cancer (eBC)?. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e12628